- Dr. Paul Glare of MSKCC commented in an article published by International Business Times about possible limitations of a new scoring system called the Prognosis in Palliative Care Study (PiPS) predictor model that might be able to inform patients in the final stages of cancer of how much time they have left so they can prepare for their passing.
- Allan Halpern of MSKCC is quoted in a Washington Post article about a quiz from Consumer Reports on skin cancer.
- Jed Wolchok of MSKCC announced the approval by the FDA of vemurafenib for metastatic melanoma.